As patients experience significant appetite suppression and reduced food intake, they may experience transient symptoms including fatigue, headache, and body discomfort
Some providers may continue titrating to higher doses (1.7 mg or 2.4 mg for Wegovy) for additional effect
To help employers balance pharmacy cost management with high-quality health benefits under their medical and pharmacy benefits, Quantum Health launched its Premier Pharmacy platform in 2024, leveraging its clinical expertise to guide members toward effective, high-value care
But they have not been compared in head-to-head trials
It runs on the OASIS 4 trial evidence base about 14% body-weight loss over 64 weeks at the highest dose
Yes, headaches are a recognised and commonly reported side effect of GLP-1 receptor agonist injections used for weight management in the UK